ExpreS2ion Biotech Holding AB (publ)

OM:EXPRS2 Stock Report

Market Cap: SEK 40.4m

ExpreS2ion Biotech Holding Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OM:EXPRS2 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
14 Dec 23SellSEK 81,250Martin JensenIndividual625SEK 130.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of EXPRS2?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders3900.0186%
Institutions238,65911.4%
General Public1,861,23088.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 63.4%.


Top Shareholders

Top 6 shareholders own 12.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.61%
BNY Asset Management
138,789SEK 2.7m0%no data
5.63%
Saxo Bank A/S, Asset Management Arm
118,340SEK 2.3m0%0.01%
0.013%
Mattis Ranthe
270SEK 5.2k0%no data
0.0065%
FCG Fonder AB
137SEK 2.6k0%no data
0.0048%
Sara Sande
100SEK 1.9k0%no data
0.00095%
Mette Thorn
20SEK 383.90%no data